Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial

BACKGROUND Intestinal mast cells may cause gastrointestinal symptoms in patients with diarrhea-dominant irritable bowel syndrome (IBS). The objective of this study was to determine the effect of mesalazine on the number of lamina propria mast cells and clinical manifestations of patients with diarrh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Middle East J Dig Dis
Asıl Yazarlar: Ghadir, Mohammad Reza, Poradineh, Mehri, Sotodeh, Masoud, Ansari, Reza, Kolahdoozan, Shadi, Hormati, Ahmad, Yousefi, Mohammad Hosein, Mirzaei, Samaneh, Vahedi, Homayoon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Iranian Association of Gastroerterology and Hepatology 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308130/
https://ncbi.nlm.nih.gov/pubmed/28316762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/mejdd.2016.47
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller